Charles River Laboratories International (CRL) Amortization of Deferred Charges (2010 - 2016)

Charles River Laboratories International's Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $506000.0 for Q4 2016.

• In Q4 2016, Amortization of Deferred Charges rose 23.41% year-over-year to $506000.0; the TTM figure through Dec 2016 stood at $2.8 million (up 18.95% YoY), while the FY2016 annual figure was $2.8 million, up 18.95% from the prior year.
• Amortization of Deferred Charges was $506000.0 for Q4 2016 at Charles River Laboratories International, up from $34000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $4.6 million in Q1 2013 to a low of $34000.0 in Q3 2016.
• Historically, Amortization of Deferred Charges has averaged $1.7 million across 5 years, with a median of $436000.0 in 2013.
• The sharpest annual moves came in 2015 and 2016: Amortization of Deferred Charges surged 165.36% in 2015, then sank 91.46% in 2016.
• A 5-year view of Amortization of Deferred Charges shows it stood at $4.5 million in 2012, then slumped by 90.26% to $437000.0 in 2013, then retreated by 2.29% to $427000.0 in 2014, then decreased by 3.98% to $410000.0 in 2015, then increased by 23.41% to $506000.0 in 2016.
• The last three Amortization of Deferred Charges figures came in at $506000.0 (Q4 2016), $34000.0 (Q3 2016), and $1.9 million (Q2 2016), per Business Quant data.